Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Trading Up ∞
The firm has a fifty day moving average of C$2.00 and a 200 day moving average of C$2.00. The firm has a market capitalization of C$21.54 million and a PE ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- Bank Stocks – Best Bank Stocks to Invest In
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Business Services Stocks Investing
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Conference Calls and Individual Investors
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
